Language: BG BG
← Back to results
Not yet recruiting NCT07527130

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Conditions: COVID-19

Sponsor: Mayo Clinic

trial.available_in: БГ
Overview
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Who can participate
Inclusion Criteria: * Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine \& Health Section or approval by MAGPIES research group. * Be able to participate fully in all aspects of the study. * Have understood and signed study informed consent. Exclusion Criteria: * Lacking the capacity to consent. * Prisoners and institutionalized individuals. * Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treatment phase and are unwilling to use a reliable form of contraception. o Acceptable forms include: * Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants * Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm) * Intrauterine device (IUD) * Total hysterectomy or tubal ligation * Abstinence (no sex). * Those patients that have implants that would prevent them from having a PET Scan. * Patients that have claustrophobia. * Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
Interventions
C11 ER176 Tracer
DRUG
Locations 1
United States (1)
Mayo Clinic
Rochester , Minnesota
Technical details
Status
Not yet recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
01.05.2026
Completion date
01.12.2027
Registry ID
NCT07527130
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.